Avid Bioservices Inc (CDMO)

[dia76ca]

In regard to DNA and Roche being interested in Bavi. In the TMCnews release of February 4 Peregine's Executive Director of Clinical and Regulatory Affairs Joe Shan is quoted as saying, "Because its mechanism is separate from the VEGF pathway in which Avastin works, there may actually be some synergies at some point in the future."
This is good business to keep the door open for a deal with Roche or DNA...and maybe even good science!